Table 3 |
|||||
|
Patterns of Metabolic Syndrome diagnostic criteria (in percent)a |
|||||
|
Group a): Non-missing data on ≥ 3 criteria but missing blood glucose data (2–18 years old) (n = 3,467) |
|||||
|
|
|||||
|
Triglycerides |
HDLb |
Obesity |
Hyperglycemia |
HTNc |
Prevalence (in %) |
|
|
|||||
|
0 |
0 |
0 |
N/A |
0 |
62.3 |
|
0 |
0 |
0 |
N/A |
1 |
3.1 |
|
0 |
0 |
1 |
N/A |
0 |
8.3 |
|
0 |
0 |
1 |
N/A |
1 |
0.9 |
|
0 |
1 |
0 |
N/A |
0 |
11.0 |
|
0 |
1 |
0 |
N/A |
1 |
0.6 |
|
0 |
1 |
1 |
N/A |
0 |
5.2 |
|
0 |
1 |
1 |
N/A |
1 |
0.9 |
|
1 |
0 |
0 |
N/A |
0 |
3.6 |
|
1 |
0 |
0 |
N/A |
1 |
0.2 |
|
1 |
0 |
1 |
N/A |
0 |
1.0 |
|
1 |
0 |
1 |
N/A |
1 |
0.2 |
|
1 |
1 |
0 |
N/A |
0 |
1.8 |
|
1 |
1 |
1 |
N/A |
0 |
1.0 |
|
1 |
1 |
1 |
N/A |
1 |
0.1 |
|
|
|||||
|
Group b): Non-missing data: ≥ 3 criteria & blood glucose but not overweight/obese (12–18 years old) (n = 1,064) |
|||||
|
|
|||||
|
Triglycerides |
HDLb |
Obesity |
Hyperglycemia |
HTNc |
Prevalence (in %) |
|
|
|||||
|
0 |
0 |
0 |
0 |
0 |
61.9 |
|
0 |
0 |
0 |
0 |
1 |
2.2 |
|
0 |
0 |
0 |
1 |
0 |
6.4 |
|
0 |
0 |
1 |
0 |
0 |
0.1 |
|
0 |
1 |
0 |
0 |
0 |
9.1 |
|
0 |
1 |
0 |
0 |
1 |
0.9 |
|
0 |
1 |
0 |
1 |
0 |
0.4 |
|
0 |
1 |
0 |
1 |
1 |
0.2 |
|
1 |
0 |
0 |
0 |
0 |
10.8 |
|
1 |
0 |
0 |
0 |
1 |
1.0 |
|
1 |
0 |
0 |
1 |
0 |
1.6 |
|
1 |
0 |
0 |
1 |
1 |
0.1 |
|
1 |
1 |
0 |
0 |
0 |
4.4 |
|
1 |
1 |
0 |
1 |
0 |
0.4 |
|
|
|||||
|
Group c): Non-missing data: ≥ 3 criteria & blood glucose & overweight or obese (12–18 years old) (n = 641) |
|||||
|
|
|||||
|
Triglycerides |
HDLb |
Obesity |
Hyperglycemia |
HTNc |
Prevalence (in %) |
|
|
|||||
|
0 |
0 |
0 |
0 |
0 |
30.6 |
|
0 |
0 |
0 |
0 |
1 |
2.4 |
|
0 |
0 |
0 |
1 |
0 |
3.4 |
|
0 |
0 |
0 |
1 |
1 |
0.2 |
|
0 |
0 |
1 |
0 |
0 |
10.7 |
|
0 |
0 |
1 |
0 |
1 |
1.1 |
|
0 |
0 |
1 |
1 |
0 |
1.4 |
|
0 |
0 |
1 |
1 |
1 |
0.7 |
|
0 |
1 |
0 |
0 |
0 |
6.2 |
|
0 |
1 |
0 |
0 |
1 |
0.8 |
|
0 |
1 |
0 |
1 |
0 |
0.9 |
|
0 |
1 |
1 |
0 |
0 |
4.2 |
|
0 |
1 |
1 |
0 |
1 |
1.0 |
|
0 |
1 |
1 |
1 |
0 |
0.7 |
|
0 |
1 |
1 |
1 |
1 |
0.2 |
|
1 |
0 |
0 |
0 |
0 |
3.5 |
|
1 |
0 |
0 |
0 |
1 |
0.3 |
|
1 |
0 |
0 |
1 |
0 |
1.3 |
|
1 |
0 |
0 |
1 |
1 |
0.1 |
|
1 |
0 |
1 |
0 |
0 |
3.4 |
|
1 |
0 |
1 |
0 |
1 |
1.1 |
|
1 |
0 |
1 |
1 |
0 |
0.5 |
|
1 |
0 |
1 |
1 |
1 |
0.7 |
|
1 |
1 |
0 |
0 |
0 |
7.3 |
|
1 |
1 |
0 |
0 |
1 |
0.9 |
|
1 |
1 |
0 |
1 |
0 |
1.3 |
|
1 |
1 |
1 |
0 |
0 |
11.2 |
|
1 |
1 |
1 |
0 |
1 |
0.7 |
|
1 |
1 |
1 |
1 |
0 |
1.7 |
|
1 |
1 |
1 |
1 |
1 |
2.0 |
|
|
|||||
|
a1 = met the criteria, 0 = did not meet the criteria, bHigh Density Lipoprotein, cHypertension |
|||||
|
Kranz et al. Nutrition Journal 2007 6:38 doi:10.1186/1475-2891-6-38 |
|||||
